Abstracts Archive - Page 977 of 2425 - ACR Meeting Abstracts

Abstract Number: 340 • 2019 ACR/ARP Annual Meeting
Increased Physical Activity in Gout Patients Correlates with Better Prognosis, Decreased Pain, and Suppressed C-Reactive Protein Levels
Naomi Schlesinger¹, Kyle Jablonski ², Peter Harb ³, Caitlin Henry ³, Emily Schwarz ³, Ifeoma Okafor ³, Wael Jarjour ⁴ and Nicholas Young ⁵, ¹Rutgers Health- RWJ Medical School, New Brunswick, NJ, ²The Ohio State University Wexner Medical Center, Division of Immunology and Rheumatology, Columbus, ³Ohio State College of Medicine, Columbus, ⁴Ohio State College of Medicine, Columbus, OH, ⁵The Ohio State University Wexner Medical Center, Division of Immunology and Rheumatology, Columbus, OH
Background/Purpose: Regular exercise programs were previously thought to be inappropriate in patients with rheumatic diseases because of the potential to exacerbate inflammation. However, while recent paradigm-shifting…
Abstract Number: 341 • 2019 ACR/ARP Annual Meeting
Development of a Multivariable Improvement Measure for Gout
Naomi Schlesinger¹, N. Lawrence Edwards ², Anthony Yeo ³ and Peter Lipsky ⁴, ¹Division of Rheumatology, Department of Medicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, ²Department of Medicine, University of Florida, Gainesville, FL, ³Horizon Therapeutics plc, Lake Forest, IL, ⁴AMPEL BioSolutions, LLC, Charlottesville, VA
Background/Purpose: Gout is a multifactorial inflammatory disease in which patients experience a wide range of signs and symptoms, including flares, inflammatory arthritis, tophi and disability.…
Abstract Number: 342 • 2019 ACR/ARP Annual Meeting
Rheumatologist Care Is Associated with Fewer Emergency Room Visits by Persons with Gout
Naomi Schlesinger¹, N. Lawrence Edwards ², Sanders Clark ³ and Peter Lipsky ⁴, ¹Division of Rheumatology, Department of Medicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, ²Department of Medicine, University of Florida, Gainesville, FL, ³HVH Precision Analytics, LLC, Wayne, PA, ⁴AMPEL BioSolutions, LLC, Charlottesville, VA
Background/Purpose: Gout is one of the most common inflammatory arthropathies, although care of gout patients is not always optimal. By searching a large administrative data…
Abstract Number: 343 • 2019 ACR/ARP Annual Meeting
Emergency Department Length of Stay in Patients with Acute Gout
Nadine Mbuyi¹, Steven Reinert ², Ross Hilliard ³, Anthony Reginato ³ and Deepan Dalal ³, ¹George Washington University, Washington, DC, ²Lifespan Health System, Providence, RI, ³Brown University, Rhode Island Hospital, Providence, RI
Background/Purpose: Emergency department (ED) visits for acute gout increased by approximately 20% between 2006 and 2014 in the United States. (1) Reducing ED length of stay…
Abstract Number: 344 • 2019 ACR/ARP Annual Meeting
Factors Associated with the Disappearance of Calcifications Following Ultrasound Guided Percutaneous Lavage of Rotator Cuff Calcific Tendinopathy: A Post Hoc Analysis of a Randomized Controlled Trial
Nicolas Dumoulin ¹, Christelle Darrieutort-Laffite ², Thomas Garraud ², Stéphane Varin ³, Guillaume Coiffier ⁴, Jean-David Albert ⁵, gregoire Cormier ⁶ and Benoit Le Goff², ¹Nantes University Hospital, Nantes, France, ²Nantes University Hospital, Nantes, ³CHD Vendée, La Roche Sur Yon, ⁴Rennes University Hospital, Rennes, ⁵Rheumatology department, Rennes University Hospital and Institut NUMECAN, INSERM U 1241, Rennes, Bretagne, France, ⁶CHD Vendée, La Roche sur Yon, France
Background/Purpose: Rotator cuff calcific tendinopathy is a common condition causing up to 20% of the painful shoulder. Ultrasound guided percutaneous lavage (UGPL) is indicated after…
Abstract Number: 345 • 2019 ACR/ARP Annual Meeting
Associations of Serum Uric Acid with Cardiovascular Disease Risk: Data from the Korea National Health and Nutrition Examination Survey
Kyong-Hee Jung¹, Seung Yun Lee ¹, Won Park ¹, Young Ju Suh ¹, Mie Jin Lim ¹, Seong-Ryul Kwon ¹, Joo-Hyun Lee ² and Young Bin Joo ³, ¹Inha University Hospital, Incheon, Republic of Korea, ²Inje University Ilsan Paik Hospital, Goyang, Republic of Korea, ³St. Vincent’s Hospital, Seoul, Republic of Korea
Background/Purpose: The cardiovascular risk of gout is already well known, and the debate over the cardiovascular risk of uric acid lower agents is currently hot.…
Abstract Number: 346 • 2019 ACR/ARP Annual Meeting
Subtypes of Gout Based on Comorbidity Patterns Among Black Patients in the US General Population – Cluster Analysis of the National Health and Nutrition Examination Survey 2007-2016
Chio Yokose¹, Na Lu ², Michael Chen-Xu ³, Natalie McCormick ⁴, Michael Pillinger ⁵, Yuqing Zhang ¹ and Hyon K. Choi ¹, ¹Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hosptial, Boston, MA, ³Capital and Coast District Health Board, Wellington, New Zealand, ⁴Massachusetts General Hospital and Harvard Medical School, Boston, MA, ⁵New York University School of Medicine, New York
Background/Purpose: Gout is a very prevalent condition associated with many metabolic and cardiorenal comorbidities. A few studies have investigated the comorbidity subtypes of gout patients…
Abstract Number: 347 • 2019 ACR/ARP Annual Meeting
Patterns and Clinico-Radiological Correlates of Symptomatic Atlantoaxial Joint Involvement in Patients with Calcium Pyrophosphate Deposition Disease
Joana Silva-Dinis¹, Catarina Tenazinha ², Nikita Khmelinskii ², Vítor Teixeira ², Pedro Ávila-Ribeiro ¹, João Eurico Fonseca ¹ and José-Carlos Romeu ², ¹Rheumatology and Bone Diseases Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte; Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa; Centro Académico de Medicina de Lisboa; Lisbon, Portugal., Lisbon, Portugal, ²Rheumatology and Bone Diseases Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte; Lisbon, Portugal., Lisbon, Portugal
Background/Purpose: Atlantoaxial joint involvement in calcium pyrophosphate deposition disease (CPPD) may present as crowned dens syndrome (CDS), a clinico-radiological tetrad defined as the presence of…
Abstract Number: 348 • 2019 ACR/ARP Annual Meeting
Patterns of Newer Gout Medication Use in a U.S. Electronic Health Record-Based Registry
Kenneth Saag¹, Andreas Reimold ², Lang Chen ¹, Huifeng Yun ¹ and Jeffrey Curtis ¹, ¹University of Alabama at Birmingham, Birmingham, AL, ²UT Southwestern Medical Center, Dallas
Background/Purpose: A variety of newer gout therapies have been introduced in recent years, some with potential safety concerns. However, uptake of these therapies and associated…
Abstract Number: 349 • 2019 ACR/ARP Annual Meeting
Carotid Atherosclerosis and Sonographic Signs of Urate Crystal Deposits in Patients with Gout: An Association Study
Irene Calabuig¹, Agustín Martínez-Sanchis ² and Mariano Andrés ³, ¹Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain, ²Hospital General Universitario de Alicante, Alicante, Spain, ³Hospital General Universitario de Alicante-ISABIAL, Universidad Miguel Hernández, Alicante, Spain
Background/Purpose: Carotid subclinical atherosclerosis is prevalent in patients with gout, although poorly predicted by cardiovascular risk assessment tools. Gout itself is deemed to contribute to…
Abstract Number: 350 • 2019 ACR/ARP Annual Meeting
Rapid Reduction in Uric Acid Is Associated with Recurrent Cardiovascular Events
Su Jin Choi¹, Jung Sun Lee ¹, So Hye Nam ¹, Doo-Ho Lim ², Ji Seon Oh ³, Seokchan Hong ⁴, Yong-Gil Kim ¹, Chang-Keun Lee ¹ and Bin Yoo ¹, ¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, ²Division of Rheumatology, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Republic of Korea, ³Department of Biomedical Informatics, Asan Medical Center, Seoul, Korea, Seoul, Republic of Korea, ⁴Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Seoul, Republic of Korea
Background/Purpose: A recent study showed that febuxostat had a higher risk of cardiovascular and all-cause mortality than allopurinol. Because febuxostat is more potent than allopurinol,…
Abstract Number: 351 • 2019 ACR/ARP Annual Meeting
Risk Factors for Cutaneous Reactions to Allopurinol in Kinh Vietnameses: Results of a Prospective Study in Ho Chi Minh City
Thomas Bardin¹, Linh Gia Le ², Quang Dinh Nguyen ³, Anh Duy Do ⁴, Hung Le ⁵, Minh Duc Do ², Anh Hoang Vu ², Anh Ngoc Le ⁶, Kim Minh Bui ³, Pascal Richette ⁷, Matthieu Resche-Rigon ⁸ and Thao Phuong Mai ⁹, ¹Vien Gut Medical Center and hopital Lariboisiere, Paris, France, ²Center for Molecular Biomedicine, University of Medicine and Pharmacy HCMC, Vietnam, Ho Chi Minh City, Vietnam, ³Vien Gut Medical Center, Ho Chi Minh City, Vietnam, ⁴Department of Physiology, Pathophysiology and Immunology - Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam, ⁵Department of Tropical Disease - Cho Ray Hospital, Ho Chi Minh City, Vietnam, ⁶Departement of Scientific Research, Cho Ray Hospital, Ho Chi Minh City, Vietnam, ⁷Department of Rheumatology, AP-HP Lariboisiere Hospital, Paris, France, ⁸Departe;ent of Biostatistics Hopital St Louis, Paris, France, ⁹Department of Physiology, Faculty of Medicine, University of Medicine and Pharmacy HCMC, Vietnam, Ho Chi Minh City, Vietnam
Background/Purpose: Allopurinol (ALLO), the leading hypouricemic drug worldwide, exposes to mild (M) and severe (S) cutaneous adverse reactions (CARs). SCARS have been associated with HLA*B-58…
Abstract Number: 352 • 2019 ACR/ARP Annual Meeting
Primary Hyperparathyroidism Is Associated with a Higher Level of Serum Uric Acid: A Systematic Review and Meta-analysis
Ben Ponvilawan ¹, Nipith Charoenngam ¹ and Patompong Ungprasert², ¹Mahidol University, Bangkok, Thailand, ²Cleveland Clinic, Cleveland, OH, Bangkok, Thailand
Background/Purpose: Studies have suggested that primary hyperparathyroidism could be a risk factor for hyperuricemia although the results were inconsistent across the studies. This systematic review…
Abstract Number: 353 • 2019 ACR/ARP Annual Meeting
Allopurinol Use and Type 2 Diabetes Incidence Among Patients with Gout: A VA Cohort Study
Anastasia Slobodnick¹, Michael Toprover ², Courtney Pike ³, Daria Crittenden ⁴, Jeffrey Greenberg ⁵ and Michael Pillinger ², ¹New York University School of Medicine, New York, NY, ²New York University School of Medicine, New York, ³Rheumatology Section, NY Harbor VA Healthcare System, New York, ⁴Amgen Inc., Thousand Oaks, CA, ⁵Corrona, LLC; NYU School of Medicine, Waltham, MA
Background/Purpose: Several studies implicate gout and/or xanthine oxidase activity as risk factors for type 2 diabetes. However, no studies have directly evaluated the effect of…
Abstract Number: 354 • 2019 ACR/ARP Annual Meeting
Evaluation of Opioid Analgesia in Hospitalized Patients with Acute Crystal Induced Arthritis
Sukhraj Singh¹, Anthony Ocon ¹, Mark Riley ², Jennifer Tchervenkov ¹ and Ruben Peredo-Wende ¹, ¹Albany Medical Center, Albany, NY, ²Albany Medical Center, Albany
Background/Purpose: The Opioid Epidemic has been declared a public health emergency since 2017. The use of opioids in the acute crystal induced arthritis (ACIA) population…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].